Institutions / Casdin Capital, LLC
Casdin Capital, LLC
CIK 1534261 · Institution · as of Dec 31, 2025
Portfolio value
$1.61B
Positions
38
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 38 →
| Company | Value | % of portfolio |
|---|---|---|
| GeneDx Holdings Corp. | $391.11M | 24.3% |
| Revolution Medicines, Inc. | $205.28M | 12.8% |
| Biolife Solutions Inc | $144.04M | 8.9% |
| Standard Biotools Inc. | $113.64M | 7.1% |
| Relay Therapeutics, Inc. | $110.01M | 6.8% |
| Structure Therapeutics Inc.GPCR | $81.72M | 5.1% |
| Illumina Inc | $78.70M | 4.9% |
| Avidity Biosciences, Inc. | $72.13M | 4.5% |
| Beam Therapeutics Inc. | $44.35M | 2.8% |
| Guardant Health, Inc. | $38.81M | 2.4% |
| Maze Therapeutics, Inc. | $31.44M | 2.0% |
| Denali Therapeutics Inc. | $30.38M | 1.9% |
| Alnylam Pharmaceuticals Inc | $29.82M | 1.9% |
| Neurogene Inc.NGNE | $26.68M | 1.7% |
| 10x Genomics, Inc. | $22.83M | 1.4% |
| ARS Pharmaceuticals, Inc. | $18.64M | 1.2% |
| Tempus AI, Inc. | $17.37M | 1.1% |
| Unitedhealth Group Inc | $16.51M | 1.0% |
| Septerna, Inc.SEPN | $15.43M | 1.0% |
| HIMS & HERS HEALTH, INC. | $12.50M | 0.8% |
| Veracyte Inc | $11.63M | 0.7% |
| Dexcom Inc | $11.61M | 0.7% |
| Scholar Rock Holding Corp | $11.45M | 0.7% |
| Cigna Group | $11.01M | 0.7% |
| Prime Medicine, Inc.PRME | $10.99M | 0.7% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.